Agios Reports Second Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
Agios Pharma (AGIO) Reports Q2 Loss of $1.47/Share
August 4, 2016 7:43 AM EDTAgios Pharma (NASDAQ: AGIO) reported Q2 EPS of ($1.47), versus ($0.85) reported last year. Revenue for the quarter came in at $6.98 million, versus $13.22 million reported last year.
For earnings history and earnings-related data on Agios Pharma (AGIO) click here.
... More